Skip to content
Tirzepatide Report
Provider review

Edessa Tirzepatide Review: Plan Prices & Refund Limits

Published by Tirzepatide ReportUpdated

On this page

Compounded tirzepatide $239 on the one-month plan; longer-plan labels and a five-month refund policy need separate comparison.

Standout details

  • Named product publishes one-, three- and six-month labels
  • Care, medication and shipping included in offer

Things to consider

  • Full longer-plan payment and renewal cadence unconfirmed
  • Terms allow final charge to vary by medicine/pharmacy

Edessa's named compounded tirzepatide page lists $239 per month for a one-month plan, $219 per month on three months, and $209 per month on six months. The table does not establish the full amount due or whether every longer plan is prepaid. Confirm the actual charge and supplied quantity rather than treating the lowest monthly label as a flexible one-month price.5

Price and care inclusions

DecisionPublished condition
One-month plan$239 per month
Three-month plan$219 per month label
Six-month plan$209 per month label
Confirm before payingTotal due, supplied quantity and recurring schedule
The product table publishes monthly labels, not full amounts due or a confirmed refill agreement.

The product includes consultation, medication, expedited shipping, ongoing check-ins and dose adjustment, with a same-price-at-every-dose promise. Its FAQ also calls the program no-contract/no-commitment, which does not by itself explain the three- and six-month price tiers. Compare the current RX Bella and Lttl reviews using actual treatment periods and complete payment terms.5

Operator, clinicians and pharmacies

Edessa Group, LLC operates the platform; independent professionals provide medical care and pharmacies prepare and dispense prescriptions. The Terms identify RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx as partners. The product footer names OpenLoop for clinical evaluation. These disclosures do not guarantee an assigned clinician or pharmacy, or independently verify their current credentials.5,6

The Prime Doctor RX review offers another clinical and pharmacy arrangement to compare. General service availability across states is qualified by medication and clinician eligibility; confirm your physical state's access before paying.6

The guarantee excludes part of the payment

The Terms provide a conditional refund when a patient can demonstrate no weight loss after following the program for at least five months, minus 25% doctor consultation fees. This is not the same as an unconditional full-purchase money-back promise. Obtain the documentation requirements and exact refund base before relying on it. The current Renlo Health review describes a separate guarantee with its own conditions.6

DecisionPublished condition
Completed consultationNonrefundable
Prescription salesGenerally final; contact support about errors
No-progress guaranteeAt least five months following program; proof required
Guarantee deduction25% doctor consultation fees excluded
The currently served Terms declare September 2025 as their update date.

The same Terms generally make completed consultations nonrefundable and prescription sales final. They also say the final card charge may vary with the prescribed medication and pharmacy, with support communicating any variance. Confirm that final charge against the product's no-hidden-fee and flat-dose language. The inspected Terms do not establish a specific subscription renewal interval or cancellation-notice deadline; discontinuing website use is not a substitute for confirming how to stop a refill.5,6

Compounded treatment and evidence

The product is compounded tirzepatide, not an FDA-approved finished Zepbound or Mounjaro product. Company sourcing claims, a rendered vial or a certification badge do not establish the quality or approval of an individual preparation. Our compounded tirzepatide guide explains that distinction.

Does the drug work? (Separate from the provider)

SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight over 72 weeks3, and SURMOUNT-5 placed it ahead of semaglutide head to head4, both on the approved brand product. Our tirzepatide evidence guide has the full picture.

Before choosing a term

Ask for the complete charge, supplied quantity, next refill date and cancellation method, plus the guarantee's evidence requirements. The current No BS RX and Renlo Health reviews offer different financial structures. Our provider comparison brings together the broader field.

Frequently asked questions

Can I pay $209 for a flexible month?

The table assigns $209 per month to a six-month plan, while the one-month plan is $239. It does not establish the full payment due or renewal terms, so confirm those details before choosing the lower label.5

What does the program include?

The named product lists clinician consultation, medication, shipping, check-ins and dose adjustments, with same-dose-price language. Terms also allow final charges to vary by prescribed medicine and pharmacy, so obtain the complete selected quote.5,6

Is the money-back guarantee a full refund?

No. Terms require demonstrating no weight loss after at least five months following the program and exclude 25% doctor consultation fees. Confirm the proof requirements and amount that would actually be refunded.6

How do renewal and cancellation work?

A specific recurring cadence and advance-notice deadline are not established in the inspected Terms. Ask support for the actual refill agreement and cancellation method. Completed consultations and prescription sales are generally nonrefundable.6

References(6)

  1. Edessa Group, LLC (2026). Compounded Tirzepatide injections product page — the "PLAN / PER MONTH" table, the "Same price, every dose" claim and the inclusions list; and the homepage product cards. myedessa.com.
  2. Edessa Group, LLC (2026). Terms of Use — the entity clause naming Edessa Group, LLC as a Nevada corporation at a Las Vegas address. myedessa.com.
  3. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  4. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  5. Edessa Group, LLC (2026). Compounded Tirzepatide: plan labels and inclusions (accessed October 26, 2026). Official provider public page.
  6. Edessa Group, LLC (2025). Terms of Use, declared update September 2025 (accessed October 26, 2026). Official provider public page.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.